Monitoring the roles of prothrombin activation fragment 1 and 2 (F1 + 2) in patients with atrial fibrillation receiving rivaroxaban and apixaban
2020 ◽
Vol 50
(2)
◽
pp. 371-379
1998 ◽
Vol 31
◽
pp. 69
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):